Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$7.41 - $10.99 $15,257 - $22,628
-2,059 Reduced 40.7%
3,000 $23,000
Q1 2021

May 07, 2021

SELL
$7.03 - $16.51 $21,090 - $49,530
-3,000 Reduced 37.23%
5,059 $42,000
Q3 2020

Nov 13, 2020

BUY
$6.17 - $18.82 $19,676 - $60,016
3,189 Added 65.48%
8,059 $89,000
Q2 2020

Aug 10, 2020

BUY
$1.73 - $6.76 $1,159 - $4,529
670 Added 15.95%
4,870 $31,000
Q1 2020

May 13, 2020

BUY
$1.57 - $4.76 $1,570 - $4,760
1,000 Added 31.25%
4,200 $8,000
Q3 2019

Nov 12, 2019

BUY
$2.05 - $2.69 $6,559 - $8,608
3,200 New
3,200 $7,000

Others Institutions Holding SRNE

About Sorrento Therapeutics, Inc.


  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Valley National Advisers Inc Portfolio

Follow Valley National Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Valley National Advisers Inc with notifications on news.